Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Evelo Biosciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −5 vs. Q4 2022
- Shares held
- 85.7M
- −1.29M (−1.5%) vs. Q4 2022
- Total value
- $15.5M
- −$124.6M (−88.9%) vs. Q4 2022
- New holders
- 5
- 9 more added
- Sold out
- 10
- 10 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $2.63K |
| Q3 2023 | 29 | $52.0M |
| Q2 2023 | 25 | $11.3M |
| Q1 2023 | 39 | $15.5M |
| Q4 2022 | 44 | $140.1M |
| Q3 2022 | 41 | $180.0M |
| Q2 2022 | 46 | $180.4M |
| Q1 2022 | 68 | $161.1M |
| Q4 2021 | 66 | $290.1M |
| Q3 2021 | 64 | $331.6M |
| Q2 2021 | 66 | $645.4M |
| Q1 2021 | 62 | $508.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Evelo Biosciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 14 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 156 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,469 | $0 | 0.00% | +1,469 | New |
| National Bank of Canada | 100 | $18 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 402 | $73 | 0.00% | +12+3.1% | Added |
| Larson Financial Group LLC | 739 | $134 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,249 | $226 | 0.00% | −98,376−98.7% | Reduced |
| China Universal Asset Management Co., Ltd. | 1,486 | $269 | 0.00% | +373+33.5% | Added |
| BNP Paribas Arbitrage, SA | 1,668 | $301 | 0.00% | +115+7.4% | Added |
| Advisor Group Holdings, Inc. | 1,500 | $326 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3,927 | $1.00K | 0.00% | +393+11.1% | Added |
| UBS Group AG | 7,990 | $1.45K | 0.00% | +3,426+75.1% | Added |
| Affinity Capital Advisors, LLC | 10,595 | $1.92K | 0.00% | +10,595 | New |
| Barclays PLC | 10,883 | $1.97K | 0.00% | −11,758−51.9% | Reduced |
| Bank of New York Mellon Corp | 13,150 | $2.38K | 0.00% | 00.0% | Unchanged |
| Avantax Planning Partners, Inc. | 15,000 | $2.71K | 0.00% | +15,000 | New |
| Virtu Financial LLC | 24,337 | $4.00K | 0.00% | +24,337 | New |
| Goldman Sachs Group Inc | 25,695 | $4.64K | 0.00% | −5,641−18.0% | Reduced |
| Tower Research Capital LLC (TRC) | 32,327 | $6.00K | 0.00% | +27,007+507.7% | Added |
| Bank of America Corp | 50,825 | $9.15K | 0.00% | +31,546+163.6% | Added |
| Morgan Stanley | 58,612 | $10.6K | 0.00% | −20,280−25.7% | Reduced |
| Millennium Management LLC | 58,418 | $11.0K | 0.00% | −35,423−37.7% | Reduced |
| Jefferies Financial Group Inc. | 75,000 | $13.6K | 0.00% | +75,000 | New |
| Northern Trust Corp | 94,330 | $17.0K | 0.00% | −640−0.7% | Reduced |
| Bridgeway Capital Management, LLC | 105,300 | $19.0K | 0.00% | 00.0% | Unchanged |
| Trustees of Columbia University in the City of New York | 113,850 | $20.6K | 0.04% | 00.0% | Unchanged |
| State Street Corp | 152,129 | $27.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 184,104 | $33.3K | 0.00% | +38,045+26.0% | Added |
| Mayo Clinic | 479,242 | $86.6K | 0.07% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 608,675 | $110.0K | 0.00% | +1,232+0.2% | Added |
| CVI Holdings, LLC | 840,577 | $151.9K | 0.06% | −630,995−42.9% | Reduced |
| Alphabet Inc. | 1,060,495 | $190.9K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 1,155,394 | $208.8K | 0.00% | −77,287−6.3% | Reduced |
| HarbourVest Partners LLC | 3,063,505 | $553.6K | 0.19% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,168,375 | $572.5K | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 3,625,415 | $655.1K | 0.00% | −52,973−1.4% | Reduced |
| State of Michigan Retirement System | 4,070,728 | $735.6K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 16,197,089 | $2.93M | 0.00% | −231,262−1.4% | Reduced |
| Flagship Pioneering Inc. | 50,427,328 | $9.11M | 0.35% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −90,291−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −61,289−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −52,699−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −52,637−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −31,345−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −29,537−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −18,511−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −10,135−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −9,952−100.0% | Sold out |
| Fairfield Financial Advisors, LTD | 0 | $0 | 0.00% | −1,075−100.0% | Sold out |